What is it about?

This article aims to discuss the pathogenesis of infections due to enterococci harboring the vanB operon (vanB VRE) and their therapeutic, state-of-the-art, and future treatment options and provide a comprehensive and easy-to-use review for clinical purposes

Featured Image

Why is it important?

It can guide clinicians for a targeted therapy against vanB VRE

Read the Original

This page is a summary of: Therapeutic Options for Infections Due to vanB Genotype Vancomycin-Resistant Enterococci, Microbial Drug Resistance, April 2021, Mary Ann Liebert Inc,
DOI: 10.1089/mdr.2020.0171.
You can read the full text:

Read

Contributors

The following have contributed to this page